SIRT6-IN-3, CAS [[3023471-40-8]]

Produktübersicht

• Artikelname: SIRT6-IN-3, CAS [[3023471-40-8]]
• Artikelnummer: MCE-HY-156027
• Hersteller Artikelnummer: HY-156027
• Alternativnummer: MCE-HY-156027-25MG,MCE-HY-156027-50MG,MCE-HY-156027-10MG,MCE-HY-156027-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

SIRT6-IN-3 (compound 8a) is a selective inhibitor of SIRT6 (IC50=7.49 µM). SIRT6-IN-3 inhibits pancreatic ductal adenocarcinoma (PDAC) cells proliferation and induces apoptosis. SIRT6-IN-3 increases the sensitivity of cancer cells to gemcitabine (HY-17026) via blocking the DNA damage repair pathway. SIRT6-IN-3 is used in pancreatic cancer research[1].

Produkteigenschaften

• Molekulargewicht: 673.73
• Reinheit: 98.19
• CAS Nummer: [3023471-40-8]
• Formel: C21H30Br3ClN6S
• Target-Kategorie: Akt,ERK,HDAC,mTOR,Ribosomal S6 Kinase (RSK),Sirtuin

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound